Results overview: Found 3 records in 0.02 seconds.
Articles, 2 records found
Research literature, 1 records found
Articles 2 records found  
1.
10 p, 328.8 KB Cannabinoids : from pot to lab / Papaseit, Esther (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Mañá, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pérez-Acevedo, Ana Pilar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hladun, Olga (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Torres-Moreno, M. Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Muga, Roberto (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Torrens, Marta (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. [...]
2018 - 10.7150/ijms.27087
International Journal of Medical Sciences, Vol. 15 (august 2018) , p. 1286-1295  
2.
16 p, 1.2 MB Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis / Torres-Moreno, Mari Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Papaseit, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Torrens, Marta (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Are medicinal cannabinoids effective and well tolerated in the treatment of multiple sclerosis? In this systematic review and meta-analysis of 17 randomized clinical trials including 3161 patients, cannabinoids were significantly associated with efficacy for subjective spasticity, pain, and bladder dysfunction compared with placebo. [...]
2018 - 10.1001/jamanetworkopen.2018.3485
JAMA network open, Vol. 1 (october 2018)  

Research literature 1 records found  
1.
378 p, 4.0 MB Eficacia y tolerabilidad de placebo y cannabinoides en esclerosis múltiple / Torres Moreno, M. Carmen ; Farre, Magi, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia
Introducció. L'esclerosi múltiple (EM) és una malaltia neurodegenerativa caracteritzada per la inflamació i la destrucció de la mielina al sistema nerviós central (SNC). Es presenta principalment en adults joves, considerant-se la primera causa de discapacitat en aquesta població. [...]
Introducción. La esclerosis múltiple (EM) es una enfermedad neurodegenerativa caracterizada por la inflamación y la destrucción selectiva de la mielina en el sistema nervioso central (SNC). Se presenta sobretodo en adultos jóvenes, siendo la primera causa de discapacidad en esta población. [...]
Background. Multiple sclerosis (MS) is a neurodegenerative disease characterized by inflammation and selective destruction of myelin in the central nervous system (CNS). It occurs mainly in young adults, being the first cause of disability in this population. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.